Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$9.6M Sell
175,061
-8,075
-4% -$457K 2.22% 14
2014
Q4
$9.92M Buy
183,136
+527
+0.3% +$29.4K 2.15% 17
2014
Q3
$10.3M Sell
182,609
-9,641
-5% -$541K 2.28% 11
2014
Q2
$10.6M Sell
192,250
-10,596
-5% -$578K 2.36% 8
2014
Q1
$11M Buy
202,846
+31,713
+19% +$1.64M 2.5% 6
2013
Q4
$8.17M Buy
171,133
+807
+0.5% +$36.9K 2.13% 13
2013
Q3
$7.74M Buy
170,326
+1,939
+1% +$88.5K 2.22% 12
2013
Q2
$7.46M Buy
+168,387
New +$7.52M 2.28% 14

Other funds holding MRK

Bank of Kentucky's MRK Position: Q1 2015 in Review

Bank of Kentucky reduced its Merck (MRK) stake by 4.4% in Q1 2015, selling an estimated $457K and leaving 175,061 shares worth $9.6M. The position accounts for 2.22% of the portfolio, ranked #14.

Bank of Kentucky first reported a position in MRK in Q2 2013 and has held it in 8 quarters since. The position peaked at $11M in Q1 2014. 1,712 funds tracked by Wall St. Rank hold MRK as of Q1 2015.

  • Bank of Kentucky held 175,061 shares of Merck worth $9.6M as of Q1 2015.
  • Bank of Kentucky sold 8,075 Merck shares in Q1 2015, an estimated $457K.
  • Merck made up 2.22% of Bank of Kentucky's portfolio in Q1 2015, its #14 holding.
  • Bank of Kentucky first reported a position in Merck in Q2 2013 and has held it in 8 quarters since.
  • Bank of Kentucky's Merck position peaked at $11M in Q1 2014.
  • 1,712 funds tracked by Wall St. Rank held Merck as of Q1 2015.

Based on Bank of Kentucky's 13F filing for Q1 2015, filed 28 Apr 2015.